Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
JP Stock MarketDetailed Quotes
4506 Sumitomo Pharma
- 579
- +1+0.17%
20min DelayMarket Closed Dec 20 15:30 JST
230.38BMarket Cap-0.73P/E (Static)
589High577Low1.50MVolume582Open578Pre Close868.95MTurnover69252wk High0.88%Turnover Ratio397.90MShares27952wk Low-703.4EPS TTM98.77BFloat Cap4135Historical HighLossP/E (Static)170.59MShs Float279Historical Low-792.79EPS LYR2.08%Amplitude--Dividend TTM2.01P/B100Lot Size--Div YieldTTM
Sumitomo Pharma News
Sumitomo Pharma: Interim report.
Stocks that moved the day before part 2: Osaka Oil Chemical Industry, Ubiquitous AI, Stem Cell Research Institute ETC.
Stock Name <Code> Closing Price on the 18th ⇒ Change from the Previous Day Toyo Securities <8614> 561 -46 Announced Share Buyback in Off-Hours Trading but feelings of exhaustion prevail. Unichika <3103> 143 -7 Continuation of negative views on stock value dilution. SOFTBANK GROUP CO <9984> 9434 -403 Following major investments in the USA, there was a significant rise on the 17th. Canon Inc-Spons Adr <7739> 2464 -48 The small rocket of Space One had a launch failure. Sumitomo Pharma <4506>
The Nikkei average has fallen for four consecutive days, while Nissan and Mitsubishi Motors have hit the stop-high, but the Index ETF has seen little movement.
On the 17th, the U.S. stock market declined. The Dow Inc average fell by 267.58 points to 43,449.90 dollars, while the Nasdaq closed down 64.83 points at 20,109.06. After opening lower due to high long-term interest rates, it continued to decline. The retail revenue for November, announced in the morning, exceeded market Financial Estimates, and while there has been no change in the view that the Federal Reserve will lower interest rates at the Federal Open Market Committee (FOMC), it has led to speculation that the pace of rate cuts next year will be gradual.
JP Movers | Nissan Motor Rose 23.70%, Leading Nikkei 225 Components, Advantest Topped Turnover List
Market sentiment was stable today as Nikkei 225 components continued to trade sideways, with Nissan Motor(7201.JP) being the top gainer today, rising 23.70% to close at 417.6 yen. In addition, the top loser was Sumitomo Pharma(4506.JP)，falling 4.46% to end at 579.0 yen.
Three points to watch in the later session - a lack of direction ahead of the Japan-U.S.-China central bank meetings.
In the trading session on the 18th, focus should be on the following three points. ・The Nikkei Average has declined for four consecutive days, showing a lack of direction ahead of the US-Japan central bank meetings. ・The dollar-yen exchange rate is slightly firm, while US interest rates have paused. ・The largest contributor to the decline is SoftBank Group <9984>, followed closely by Fast Retailing <9983>. ■The Nikkei Average has declined for four consecutive days, displaying a lack of direction ahead of the US-Japan central bank meetings, with a decrease of 83.62 yen (-0.21%) to 39,281.06 yen, and volume estimated at 1.1 billion 60 million shares.
The Nikkei average has fallen for four consecutive days, showing a lack of direction ahead of the Japan-U.S. central bank meetings.
The Nikkei average fell for the fourth consecutive day. It ended the morning session at 39,281.06 yen, down 83.62 yen (-0.21%) from the previous day (estimated Volume 1.1 billion 60 million Stocks). The US stock market on the 17th declined. The Dow Inc fell by 267.58 dollars to 43,449.90 dollars, and the Nasdaq dropped by 64.83 points to 20,109.06. Long-term Gold rates remained high and fell after the opening. The retail revenue for November, announced in the morning, exceeded market Financial Estimates, leading the Federal Reserve Board (FRB) to...
Three points to focus on in the first half of the market - short-term trading is the main focus while waiting for the results of the FOMC.
In the trading session before noon on the 18th, I would like to focus on the following three points. ■ Short-term trading is the focus while waiting for the FOMC results. ■ Estelle, 2Q operating loss, deficit narrowed by ▲0.317 billion yen. ■ Materials of interest in the morning session: Toyota's Lexus "UX" production has ended, focusing on next-generation EVs. ■ The Japanese stock market on the 18th is likely to exhibit a strong sense of stagnation. In the US market on the 17th, the Dow Jones Industrial Average fell by 267 points, while the Nasdaq dropped by 64 points. Morning updates...
Toyota Motor, Sumitomo Pharma, etc.
*Toyota <7203> ends production of the Lexus 'UX' and focuses on next-generation EVs (Nikkankogyo, page 1) - ○ *Honda <7267> aims to double hybrid vehicle production by 2030, targeting global sales of 1.3 million units per year (Nikkankogyo, page 1) - ○ *Sumitomo Pharma <4506> and Sumitomo Chemicals establish a new company for regenerative and cell medicine, aiming for a scale of 350 billion yen in the late 2030s (Nikkankogyo, page 3) - ○ *Tokyo Gas <9531> signs an agreement with McDonald's to supply renewable energy to 75 stores in the Kanto area (Nikkankogyo, page 3) - ○ *Japan Escon <8892> Mitsubishi Chemicals.
Japanese Stocks End Flat
The Nikkei Average fell for the first time in five days, influenced by the decline in U.S. stocks and a sense of achievement, etc.
The Nikkei Index fell for the first time in five days. It ended the morning session at 39,360.43 yen, down 488.71 yen (-1.23%) from the previous day (Volume estimated at 1.2 billion Stocks). On the 12th, the U.S. stock market declined. The Dow Inc decreased by 234.44 dollars to 43,914.12 dollars, and the Nasdaq dropped by 132.05 points to 19,902.84. There was concern over an unexpectedly accelerated Producer Price Index (PPI) for November, leading to a decline after the market opened. The Dow Inc was affected by unexpectedly weak employment-related indicators.
Nikkei Average Contribution Ranking (Pre-close) ~ The Nikkei Average declined for the first time in three days, with Advantest dragging down by about 58 yen from a single stock.
As of the close 11 days ago, the number of rising and falling stocks in the Nikkei average consisted of 79 stocks that rose, 144 stocks that fell, and 2 stocks that remained unchanged. The Nikkei average fell for the first time in three days, ending the morning session at 39,112.80 yen, down 254.78 yen (−0.65%) from the previous day, with an estimated Volume of 0.7 billion 70 million shares. On the 10th, the US stock market continued to decline. The Dow Inc dropped by 154.10 dollars to close at 44,247.83 dollars, while the Nasdaq fell by 49.45 points to end at 19,687.24.
Three key points to watch in the afternoon session - a wait-and-see attitude strengthens ahead of the US CPI announcement.
In the afternoon trading on the 11th, I would like to focus on the following three points. • The Nikkei average fell for the first time in three days, as a wait-and-see attitude strengthened ahead of the U.S. CPI announcement. • The dollar-yen exchange rate is soft, with yen buying prevailing. • The biggest contributor to the decline was Advantest <6857>, and the second was Fast Retailing <9983>. ■ The Nikkei average fell for the first time in three days, and the wait-and-see attitude strengthened ahead of the U.S. CPI announcement. The Nikkei average fell by 254.78 yen (−0.65%) from the previous day to 39,112.80 yen (estimated Volume 0.7 billion yen).
The Nikkei index fell for the first time in three days, as caution increased ahead of the U.S. CPI announcement.
The Nikkei average fell for the first time in three days. It ended the morning session at 39,112.80 yen, down 254.78 yen (-0.65%) from the previous day (estimated Volume 0.7 billion 70 million stocks). On the 10th, the US stock market continued to decline. The Dow Inc average closed down 154.10 dollars at 44,247.83 dollars, while the Nasdaq closed down 49.45 points at 19,687.24. A lack of materials led to mixed trading, and after the opening, the market was varied. The Dow was pressured by selling due to high price caution, and remained weak throughout the day.
List of Switching Stocks (Part 1) [Parabolic Signal Switching Stocks List]
○ List of stocks for Buy conversion in the market Code Stock Name Closing Price SAR Main Board <1605> INPEX 1982 1944 <1662> Petroleum Resources 1096 1056 <1938> Nihon Reitech 1127 1082 <1939> Shikoku Electric Power 1468 1427 <2127> Japan M&A 6496 616 <2150> CareNet 5915 71 <2335> CubeSys 1066 1037 <26
List of cloud-breaking stocks [Ichimoku Kinko Hyo - List of cloud-breaking stocks]
○ List of stocks breaking through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1963> JGC Holdings Corporation 1299 1285.75 1260 <2127> Japan M&A 649639640 <2157> Koshidaka HD 1166 1157.5 1083 <3116> Toyota Boshoku 1999 1969.75 1929.5 <3397> Toridoll 3890 3858.5 3680
Stocks that moved the previous day part 1: Gakujo, Topcon, Saizeriya, ETC.
Stock name <code> Closing price on the 10th ⇒ Comparison with the previous day A-Mobile <6535> 499 -42 Operating profit decreased by 46.1% in the first quarter. Niitaka <4465> 1955 +63 Revised upwards the Financial Estimates for net profit and Dividends for the fiscal year ending May 2025. Miraiar <4238> 1373 -84 Operating profit for the fiscal year ending January 2025, which had not been disclosed, is predicted to decrease by 10.0%. CEC <9692> 1967 -83 Revised downwards the Financial Estimates for net profit for the fiscal year ending January 2025. Ururu <3979> 1365 +21 Simp
JP Movers | Sumitomo Pharma Rose 6.07%, Leading Nikkei 225 Components, IHI Topped Turnover List
Market sentiment was stable today as Nikkei 225 components continued to trade sideways, with Sumitomo Pharma(4506.JP) being the top gainer today, rising 6.07% to close at 612.0 yen. In addition, the top loser was Fujikura(5803.JP)，falling 5.45% to end at 5851.0 yen.
Express News | Japanese stock market closing: the nikkei 225 index rose by 0.53%, and Sumitomo Pharma increased by over 6%.
Helios Research Memo (2): A biotech venture advancing the research, development, and manufacturing of cellular pharmaceuticals and regenerative medicine products.
■ Helios <4593> company overview 1. Company history Helios operates with the task center of "Increasing 'Life'. Explosively." The company is a biotech venture engaged in research, development, and manufacturing of cellular pharmaceuticals and regenerative medicine products in fields where new treatments are desired, such as major causes of death in developed countries (ARDS: respiratory field, cerebral infarction: neurology field, solid tumors: oncology field). It was established in 2011 by Mr. Tadahisa Kagimoto, the current representative executive officer and a former ophthalmologist.
Sumitomo Pharma (TSE:4506) Eyes Growth With ORGOVYX Success and Key Alliances Despite Financial Strain